Axxcess Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Buy |
7,063
+33
| +0.5% | +$2.16K | 0.01% | 607 |
|
|
2025
Q1 | $496K | Buy |
7,030
+2,029
| +41% | +$143K | 0.01% | 558 |
|
|
2024
Q4 | $329K | Buy |
5,001
+1,607
| +47% | +$106K | 0.01% | 649 |
|
|
2024
Q3 | $240K | Buy |
3,394
+17
| +0.5% | +$1.2K | 0.01% | 770 |
|
|
2024
Q2 | $224K | Buy |
3,377
+15
| +0.4% | +$995 | 0.01% | 753 |
|
|
2024
Q1 | $228K | Buy |
3,362
+14
| +0.4% | +$950 | 0.01% | 761 |
|
|
2023
Q4 | $207K | Buy |
+3,348
| New | +$207K | 0.01% | 774 |
|
|
2023
Q1 | – | Sell |
-3,300
| Closed | -$205K | – | 660 |
|
|
2022
Q4 | $205K | Buy |
+3,300
| New | +$205K | 0.02% | 559 |
|